G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 118 filers reported holding G1 THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $20,740 | -70.4% | 2,729 | -60.3% | 0.00% | 0.0% |
| Q4 2021 | $70,102 | -38.1% | 6,866 | -18.7% | 0.00% | -50.0% |
| Q3 2021 | $113,292 | -53.4% | 8,442 | -23.9% | 0.00% | -33.3% |
| Q2 2021 | $243,249 | -8.8% | 11,087 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $266,753 | +33.7% | 11,087 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $199,455 | +55.8% | 11,087 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $128,055 | -52.4% | 11,087 | 0.0% | 0.00% | -60.0% |
| Q2 2020 | $268,971 | +120.1% | 11,087 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $122,179 | -58.3% | 11,087 | 0.0% | 0.00% | -40.0% |
| Q4 2019 | $293,029 | +10.9% | 11,087 | -4.4% | 0.01% | +25.0% |
| Q3 2019 | $264,248 | +12.4% | 11,600 | +51.3% | 0.00% | 0.0% |
| Q2 2019 | $235,009 | +84.7% | 7,665 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $127,239 | -13.3% | 7,665 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $146,785 | -58.8% | 7,665 | +12.4% | 0.00% | -50.0% |
| Q3 2018 | $356,513 | -99.9% | 6,818 | 0.0% | 0.01% | +20.0% |
| Q2 2018 | $296,311,000 | +74.1% | 6,818 | +48.4% | 0.01% | +150.0% |
| Q1 2018 | $170,207,000 | – | 4,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |